Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?

In the last 20 years, novel non-seasonal influenza viruses have emerged, most of which have originated from birds. Despite their apparent inability to cause pandemics, with the exception of H1N1 swine influenza virus, these viruses still constitute a constant threat to public health. While general concern has decreased after the peak of the H5N1 virus, in recent years several novel reassorted influenza viruses (e.g., H7N9, H9N2, H10N8) have jumped the host-species barrier and are under surveillance by the scientific community and public health systems. It is still unclear whether these viruses can actually cause pandemics or just isolated episodes. The purpose of this review is to provide an overview of old and novel potential pandemic strains of recent decades.

[1]  Wenjun Song,et al.  Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome , 2013, The Lancet.

[2]  Y. Guan,et al.  Genetic tuning of the novel avian influenza A(H7N9) virus during interspecies transmission, China, 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  R. Cox,et al.  An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans , 2014, Clinical and Vaccine Immunology.

[4]  R. Cox,et al.  A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models , 2009, Influenza and other respiratory viruses.

[5]  M. Peiris,et al.  Human infection with influenza H9N2 , 1999, The Lancet.

[6]  A. Monto,et al.  Vaccines and Antiviral Drugs in Pandemic Preparedness , 2006, Emerging infectious diseases.

[7]  Joel Kelso,et al.  Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines , 2010, Journal of The Royal Society Interface.

[8]  British Columbia,et al.  Human Illness from Avian Influenza H7N3 , 2004 .

[9]  Jiankang Han,et al.  Persistent detection of avian influenza A/H7N9 virus among poultry in Huzhou City, China, in the summer of 2013. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[10]  J. Makkoch,et al.  Global alert to avian influenza virus infection: From H5N1 to H7N9 , 2013, Pathogens and global health.

[11]  Jun Yu Li,et al.  Limited human-to-human transmission of avian influenza A(H7N9) virus, Shanghai, China, March to April 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  E. Padlan The pandemic 2009 (H1N1) swine influenza virus is mild compared to the pandemic 1918 (H1N1) virus because of a proline-to-serine substitution in the receptor-binding site of its hemagglutinin - a hypothesis. , 2010, Medical hypotheses.

[13]  D. Bernstein,et al.  Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial. , 2014, JAMA.

[14]  K. Neuzil,et al.  Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine , 2014, PloS one.

[15]  P. N. Barrett,et al.  Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults , 2014, Clinical and Vaccine Immunology.

[16]  I. Donatelli,et al.  Influenza surveillance in birds in Italian wetlands (1992-1998): is there a host restricted circulation of influenza viruses in sympatric ducks and coots? , 2004, Veterinary microbiology.

[17]  Y. Guan,et al.  H9N2 Influenza Viruses Possessing H5N1-Like Internal Genomes Continue To Circulate in Poultry in Southeastern China , 2000, Journal of Virology.

[18]  K. Subbarao,et al.  Development of a High-Yield Live Attenuated H7N9 Influenza Virus Vaccine That Provides Protection against Homologous and Heterologous H7 Wild-Type Viruses in Ferrets , 2014, Journal of Virology.

[19]  P. Horby,et al.  Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. , 2012, The Lancet. Infectious diseases.

[20]  J. Treanor Expanding the options for confronting pandemic influenza. , 2014, JAMA.

[21]  W. Keitel,et al.  Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial. , 2010, Vaccine.

[22]  J. Noh,et al.  Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine , 2011, Clinical and Vaccine Immunology.

[23]  I. Donatelli,et al.  A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. , 2009, Vaccine.

[24]  G. Gao,et al.  H7N9: a low pathogenic avian influenza A virus infecting humans , 2014, Current Opinion in Virology.

[25]  R. Brunham,et al.  Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada , 2006, Canadian Medical Association Journal.

[26]  Fabrice Carrat,et al.  Transmissibility and geographic spread of the 1889 influenza pandemic , 2010, Proceedings of the National Academy of Sciences.

[27]  Libo Dong,et al.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.

[28]  C. Hohenadl,et al.  Immunogenicity and Protective Efficacy of a Vero Cell Culture-Derived Whole-Virus H7N9 Vaccine in Mice and Guinea Pigs , 2015, PloS one.

[29]  V. Cheng,et al.  Emergence in China of human disease due to avian influenza A(H10N8)--cause for concern? , 2014, The Journal of infection.

[30]  J. Tam,et al.  Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011. , 2011, Vaccine.

[31]  P. Palese,et al.  Unraveling the Mystery of Swine Influenza Virus , 2009, Cell.

[32]  S. Lal,et al.  H7N9: A killer in the making or a false alarm? , 2014, Canadian journal of microbiology.

[33]  A. García-Sastre,et al.  A Reassortment-Incompetent Live Attenuated Influenza Virus Vaccine for Protection against Pandemic Virus Strains , 2011, Journal of Virology.

[34]  Miquel Porta,et al.  A Dictionary of Epidemiology , 2008 .

[35]  Jinquan Cheng,et al.  Seroprevalence to avian influenza A(H7N9) virus among poultry workers and the general population in southern China: a longitudinal study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  R. Webster,et al.  Replication of avian influenza viruses in humans , 2005, Archives of Virology.

[37]  R. Webster,et al.  A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets. , 2014, Vaccine.

[38]  A. Osterhaus,et al.  Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control , 2009, Human vaccines.

[39]  Ron A M Fouchier,et al.  Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.

[40]  Tatsuya Nishi,et al.  Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/119/2008 (H7N9) against the challenge with A/Anhui/1/2013 (H7N9). , 2014, Vaccine.

[41]  Jie Dong,et al.  Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. , 2018 .

[42]  A. García-Sastre,et al.  Avian influenza A H10N8—a virus on the verge? , 2014, The Lancet.

[43]  W. Keitel,et al.  Influenza A(H5N1) Vaccines: Are We Better Prepared for the Next Pandemic? , 2013, The Journal of infectious diseases.

[44]  L. Rudenko,et al.  H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic? , 2014, Expert review of vaccines.

[45]  K. Nichol,et al.  Vaccines for seasonal and pandemic influenza. , 2006, The Journal of infectious diseases.

[46]  R. Compans,et al.  Immunity to Pre-1950 H1N1 Influenza Viruses Confers Cross-Protection against the Pandemic Swine-Origin 2009 A (H1N1) Influenza Virus , 2010, The Journal of Immunology.

[47]  S. D. de Vlas,et al.  Serological reports of human infections of H7 and H9 avian influenza viruses in northern China. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[48]  G. Gray,et al.  First evidence of H10N8 Avian influenza virus infections among feral dogs in live poultry markets in Guangdong province, China. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  G. Leroux-Roels,et al.  Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age. , 2015, Vaccine.

[50]  N. Cox,et al.  Global concerns regarding novel influenza A (H7N9) virus infections. , 2013, The New England journal of medicine.

[51]  R. Gasparini,et al.  Live attenuated influenza vaccine--a review. , 2011, Journal of preventive medicine and hygiene.

[52]  S. Opal,et al.  The controversy over H5N1 transmissibility research , 2013, Human vaccines & immunotherapeutics.

[53]  H. Jin,et al.  Development of live attenuated influenza vaccines against pandemic influenza strains , 2014, Expert review of vaccines.

[54]  G. Milne,et al.  Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis , 2013, BMC Infectious Diseases.

[55]  Weizhong Yang,et al.  Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study , 2014, The Lancet.

[56]  T. Popović,et al.  Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. , 2009, MMWR. Morbidity and mortality weekly report.

[57]  E. Faerstein,et al.  A DICTIONARY OF EPIDEMIOLOGY , 2016 .

[58]  L. Rudenko,et al.  Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus , 2015, Expert review of vaccines.

[59]  Marion Koopmans,et al.  Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Keiji Fukuda,et al.  Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays , 1999, Journal of Clinical Microbiology.

[61]  G. Air,et al.  Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans , 2012, PloS one.

[62]  Ming Wang,et al.  Antibodies against H5 and H9 avian influenza among poultry workers in China. , 2009, The New England journal of medicine.

[63]  R. Walker,et al.  Live attenuated versus inactivated influenza vaccine in infants and young children. , 2007, The New England journal of medicine.

[64]  L. Rudenko,et al.  H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus. , 2013, Vaccine.

[65]  B. Kumar,et al.  Emerging influenza virus: A global threat , 2008, Journal of Biosciences.

[66]  H. Fineberg Pandemic preparedness and response--lessons from the H1N1 influenza of 2009. , 2014, The New England journal of medicine.

[67]  C. Hohenadl,et al.  A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate. , 2012, Vaccine.

[68]  R. Gao,et al.  Genesis of the novel human-infecting influenza A(H10N8) virus and potential genetic diversity of the virus in poultry, China. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[69]  Ke Xu,et al.  Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation , 2013, BMJ.

[70]  E. Montomoli,et al.  Is influenza A/H10N8 a potential candidate for the next pandemic? , 2014, Pathogens and global health.

[71]  G. Gao,et al.  Continuous reassortments with local chicken H9N2 virus underlie the human-infecting influenza A (H7N9) virus in the new influenza season, Guangdong, China , 2014, Protein & Cell.

[72]  J. Chan,et al.  The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities , 2013, The Lancet Infectious Diseases.

[73]  Y. Guan,et al.  Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Martin Hirst,et al.  Human Illness from Avian Influenza H7N3, British Columbia , 2004, Emerging infectious diseases.

[75]  Yi Guan,et al.  Human Infection with an Avian H9N2 Influenza A Virus in Hong Kong in 2003 , 2005, Journal of Clinical Microbiology.

[76]  X. Kan,et al.  Origin and molecular characteristics of a novel 2013 avian influenza A(H6N1) virus causing human infection in Taiwan. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[77]  P. Dormitzer,et al.  A Cell Culture–Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in Adults , 2014, Science Translational Medicine.

[78]  C. Ambrose,et al.  Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza , 2008, Influenza and other respiratory viruses.

[79]  E. Lau,et al.  Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A(H7N9) infections in China, March to April 2013. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[80]  R. Webster,et al.  H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. , 2001, Virology.

[81]  B. Ligon,et al.  Avian influenza virus H5N1: a review of its history and information regarding its potential to cause the next pandemic. , 2005, Seminars in pediatric infectious diseases.

[82]  R. Jacobson,et al.  Avian and pandemic influenza: an overview. , 2007, Vaccine.

[83]  Ching-Yuan Chang,et al.  Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses. , 2014, Vaccine.

[84]  S. Inglis,et al.  Prospects for controlling future pandemics of influenza. , 2011, Virus research.

[85]  T. Tumpey,et al.  Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility , 2008, Proceedings of the National Academy of Sciences.

[86]  Thomas D Szucs,et al.  Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. , 2008, The Lancet. Infectious diseases.

[87]  H. Liu,et al.  Transmission of avian influenza A(H7N9) virus from father to child: a report of limited person-to-person transmission, Guangzhou, China, January 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[88]  S. Vong Editorial commentary: some perspectives regarding risk factors for a(H7N9) influenza virus infection in humans. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.